A detailed history of Auour Investments LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Auour Investments LLC holds 21,020 shares of TYRA stock, worth $295,751. This represents 0.18% of its overall portfolio holdings.

Number of Shares
21,020
Previous 85,020 75.28%
Holding current value
$295,751
Previous $1.36 Million 63.65%
% of portfolio
0.18%
Previous 0.51%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$16.7 - $24.36 $1.07 Million - $1.56 Million
-64,000 Reduced 75.28%
21,020 $494,000
Q2 2023

Jul 07, 2023

BUY
$11.99 - $17.51 $1.02 Million - $1.49 Million
85,020 New
85,020 $1.45 Billion

Others Institutions Holding TYRA

About Tyra Biosciences, Inc.


  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $591M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track This Portfolio

Track Auour Investments LLC Portfolio

Follow Auour Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Auour Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Auour Investments LLC with notifications on news.